What is NUCLEAR?

NUCLEAR: ELUCIDATING METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY WITH RELEVANCE TO STEM CELL BIOLOGY AND CANCER

NUCLEAR is a Marie Skłodowska Curie Action Doctoral Network funded by the European Commission under the Horizon Europe framework programme.

NUCLEAR will train 17 Doctoral candidates (DC) in the emerging field of Metabolic Regulation of Genome Function and Cell Identity, relevant for stem cell biology and cancer. In total, there are 14 beneficiaries and 12 partner organisations.

NUCLEAR will bring together European leaders in the fields of metabolomicsfunctional genomicschromatin regulationstem cell biology, and cancer with innovators in precision nutrition, mass spectrometry technologies, and drug development.

NUCLEAR project aims to develop tools for the detection of metabolism in the nucleus, to understand how metabolism regulates functions of the chromatin template and to test metabolism-chromatin interactions as targetable vulnerabilities in cancer cells

NEWS

18.11.2024

Breaking new ground in cancer and stem cell research: the NUCLEAR project launches

With a focus on stem cell biology and cancer, NUCLEAR will train 17 doctoral candidates in cutting-edge research. Supported by 14 beneficiaries and 12 partner organizations across Europe, the initiative combines expertise in metabolomics, functional genomics, chromatin regulation, and cancer biology.

SOCIAL MEDIA

Posts by NuclearDn

https://bsky.app/profile/nucleardn.bsky.social